特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
349964

qPCR試薬の世界市場の予測 ~2020年:検出法 (染料系・プローブ)・パッケージ (qPCRコアキット・マスターミックス)・エンドユーザー (病院&診断センター・学術機関・研究ラボ・CRO)・用途 (診断・研究・法医学) 別

qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecasts to 2020

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 160 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.81円
qPCR試薬の世界市場の予測 ~2020年:検出法 (染料系・プローブ)・パッケージ (qPCRコアキット・マスターミックス)・エンドユーザー (病院&診断センター・学術機関・研究ラボ・CRO)・用途 (診断・研究・法医学) 別
出版日: 2016年01月15日
発行: MarketsandMarkets
ページ情報: 英文 160 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のqPCR試薬の市場は2015年から2020年にかけて7.7%のCAGRで推移し、2015年の13億700万米ドルから、2020年には18億9390万米ドルの規模に成長すると予測されています。感染症や遺伝子疾患の患者人口の増加や高齢者人口の増加、ライフサイエンス部門における技術の進歩、PCR関連の研究に対する官民からの投資やファンド、助成の拡大、ヒトゲノムプロジェクトの成功などの要因が同市場の成長を推進しています。

当レポートでは、世界のqPCR試薬の市場を調査し、製品および市場の概要、市場影響因子および市場機会の分析、産業構造とバリューチェーン、検出法・パッケージ・エンドユーザー・用途別の主な動向および市場成長予測、地域および主要国の動向、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界市場の推移と予測
  • 世界市場の規模の実績・予測:検出法別
  • 世界市場のシェア実績:パッケージタイプ別
  • 世界市場の規模実績:用途別
  • 世界市場の規模の実績・予測:エンドユーザー別

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場動態
    • 成長促進要因
    • 成長阻害要因
    • 市場機会
    • 課題

第6章 産業動向

  • イントロダクション
  • バリューチェーン分析
  • サプライチェーン分析
  • 産業動向
  • ポーターのファイブフォース分析

第7章 市場分析:検出法別

  • イントロダクション
  • 染料系qPCR試薬
  • プローブ&プライマーqPCR試薬

第8章 市場分析:パッケージタイプ別

  • イントロダクション
  • qPCRコアキット
  • qPCRマスタープレミックス

第9章 市場分析:エンドユーザー別

  • イントロダクション
  • 病院・診断センター
  • 研究ラボ・学術機関
  • 医薬品・バイオテクノロジー企業
  • 医薬品開発業務受託機関 (CRO)
  • 法医学研究所

第10章 市場分析:用途別

  • イントロダクション
  • 診断
  • 研究
  • 法医学

第11章 市場分析:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • その他の地域

第12章 競合環境

  • 概要
  • 市場シェア分析
  • 競合シナリオ
  • 近年の発展動向
    • 新製品の投入・製品の承認
    • 合意・協力・提携
    • M&A・分割
    • 拡張

第13章 企業プロファイル

  • イントロダクション
  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • F. HOFFMAN-LA ROCHE LTD.
  • QIAGEN N.V.
  • AGILENT TECHNOLOGIES, INC.
  • タカラバイオ
  • AFFYMETRIX, INC.
  • SIGMA-ALDRICH CORPORATION
  • PROMEGA CORPORATION
  • QUANTA BIOSCIENCES,
    • 財務動向
    • 製品・サービス
    • 主要戦略
    • 近年の動向、など

第14章 付録

図表

目次
Product Code: BT 3999

The Global qPCR reagents market is poised to reach ~USD 1,893.9 million by 2020 From USD 1,307.0 million in 2015, growing at a CAGR of 7.7%, during 2015 to 2020. North America is expected to hold the largest share of the global qPCR reagents market in 2015. Market growth of qPCR reagents is being propelled by rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.

In this report, the global qPCR reagents market is segmented on the basis detection method (dye-based and probe & primer-based qPCR reagents), packaging type (core kits and mastermixes), end user (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, clinical research organizations, and forensic laboratories), and application (diagnostic, research, and forensic).

The qPCR core kits segment is expected to account for the larger share of the global qPCR reagents market in 2015, followed by mastermixes. Significant demand growth for qPCR core kits is owing to low prices of core kits (as compared to mastermixes), flexibility offered to end users (as it is best suited for researchers to develop independent reaction protocols), growing private-public funding for life science research, and increasing market availability of qPCR core kits across major countries.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global qPCR reagents market in 2015, followed by Europe. Asia-Pacific is poised to grow at the highest CAGR during the forecast period, owing to factors such as growing incidences of criminal cases across the globe, improving knowledge about human and microbial genome, increasing laboratory automation in forensic laboratories, and various statistical and technical advancements in the field of qPCR.

The global qPCR reagents market is highly competitive, with various global as well as local players. In 2014, the global qPCR reagents devices market was dominated by Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Qiagen N.V. (Netherlands); which together accounted for ~75.0% of the qPCR reagents market. New product launches, agreements, collaborations, partnerships, geographic expansions, mergers, demergers, strategic acquisitions, awareness campaigns, and offering research fund & grants are the major strategies adopted by most market players to achieve growth in the global qPCR reagents market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the qPCR reagents market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms to garner higher market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the qPCR reagents offered by the top 10 players in the global market. The report analyzes the qPCR reagents market by detection method, packaging type, end user, and application across key geographic regions
  • Product Development/Innovation: Detailed insights on upcoming qPCR reagents, research and development activities, and new product launches in the market
  • Market Development: Comprehensive information on lucrative emerging markets. The report analyzes the markets for various qPCR reagents across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global qPCR reagents market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global qPCR reagents market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. STUDY OBJECTIVES
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. FACTOR ANALYSIS
    • 2.2.1. INTRODUCTION
    • 2.2.2. DEMAND-SIDE ANALYSIS
      • 2.2.2.1. Healthcare expenditure patterns
      • 2.2.2.2. Rapid growth of aging population
      • 2.2.2.3. Incidence and prevalence of cancer
      • 2.2.2.4. Birth rate/pregnancies
      • 2.2.2.5. Burden of infectious diseases
      • 2.2.2.6. Number of clinical, forensic, and research laboratories
    • 2.2.3. SUPPLY-SIDE ANALYSIS
      • 2.2.3.1. Number of new product launches: qPCR Reagents Vs. Competitive Technologies
      • 2.2.3.2. Parent market analysis: Polymerase chain reaction (PCR) market
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS
    • 2.5.1. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. HISTORY, EVOLUTION, AND CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL qPCR REAGENTS MARKET (2015-2020)
  • 4.2. GLOBAL qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD (2015 VS. 2020)
  • 4.3. GLOBAL qPCR REAGENTS MARKET SHARE, BY PACKAGING TYPE (2015)
  • 4.4. GLOBAL qPCR REAGENTS MARKET SIZE, BY APPLICATION (2015)
  • 4.5. GLOBAL qPCR REAGENTS MARKET SIZE, BY END USER (2015 VS. 2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. KEY MARKET DRIVERS
      • 5.3.1.1. Rising incidence of infectious diseases and genetic disorders
      • 5.3.1.2. Growing geriatric population
      • 5.3.1.3. Technological advancements
      • 5.3.1.4. Increasing public-private investments, funds, and grants
      • 5.3.1.5. Successful completion of the human genome project
    • 5.3.2. KEY MARKET RESTRAINTS
      • 5.3.2.1. Technical limitations associated with qPCR
    • 5.3.3. KEY MARKET OPPORTUNITIES
      • 5.3.3.1. Growing market penetration in emerging countries
      • 5.3.3.2. Shift from plant-derived to genome-based drug discovery
    • 5.3.4. KEY MARKET CHALLENGES
      • 5.3.4.1. Adoption and implementation of MIQE guidelines for publishing qPCR-based research

6. INDUSTRY TRENDS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. SUPPLY CHAIN ANALYSIS
  • 6.4. INDUSTRY TRENDS
  • 6.5. PORTER'S FIVE FORCES ANALYSIS
    • 6.5.1. THREAT FROM NEW ENTRANTS
    • 6.5.2. THREAT FROM SUBSTITUTES
    • 6.5.3. BARGAINING POWER OF SUPPLIERS
    • 6.5.4. BARGAINING POWER OF BUYERS
    • 6.5.5. INTENSITY OF COMPETITIVE RIVALRY

7. qPCR REAGENTS MARKET, BY DETECTION METHOD

  • 7.1. INTRODUCTION
  • 7.2. DYE-BASED qPCR REAGENTS
  • 7.3. PROBES AND PRIMER-BASED qPCR REAGENTS

8. qPCR REAGENTS MARKET, BY PACKAGING TYPE

  • 8.1. INTRODUCTION
  • 8.2. qPCR CORE KITS
  • 8.3. qPCR MASTERMIXES

9. qPCR REAGENTS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS & DIAGNOSTIC CENTERS
  • 9.3. RESEARCH LABORATORIES & ACADEMIC INSTITUTES
  • 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.5. CLINICAL RESEARCH ORGANIZATIONS (CROS)
  • 9.6. FORENSIC LABORATORIES

10. qPCR REAGENTS MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. DIAGNOSTIC APPLICATIONS
  • 10.3. RESEARCH APPLICATIONS
  • 10.4. FORENSIC APPLICATIONS

11. QPCR REAGENTS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. U.K.
    • 11.3.3. FRANCE
    • 11.3.4. REST OF EUROPE (RoE)
  • 11.4. ASIA-PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA-PACIFIC (RoAPAC)
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SCENARIO
  • 12.4. RECENT DEVELOPMENTS
    • 12.4.1. NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS
    • 12.4.2. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 12.4.3. MERGERS, DEMERGERS, AND ACQUISITIONS
    • 12.4.4. EXPANSION

13. COMPANY PROFILE*

  • 13.1. INTRODUCTION
    • 13.1.1. GEOGRAPHIC BENCHMARKING
    • 13.1.2. STRATEGIC BENCHMARKING
      • 13.1.2.1. Product development and commercialization
  • 13.2. THERMO FISHER SCIENTIFIC INC.
  • 13.3. BIO-RAD LABORATORIES, INC.
  • 13.4. F. HOFFMAN-LA ROCHE LTD.
  • 13.5. QIAGEN N.V.
  • 13.6. AGILENT TECHNOLOGIES, INC.
  • 13.7. TAKARA BIO INC.
  • 13.8. AFFYMETRIX, INC.
  • 13.9. SIGMA-ALDRICH CORPORATION (A SUBSIDIARY OF MERCK KGAA, GERMANY)
  • 13.10. PROMEGA CORPORATION
  • 13.11. QUANTA BIOSCIENCES, INC.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: qPCR REAGENTS INDUSTRY FOCUSES ON TECHNOLOGICAL INTEGRATION TO DEVELOP ADVANCED PRODUCTS WITH DIVERSE APPLICATION AREAS
  • TABLE 2: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 3: DYE-BASED qPCR REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 4: PROBES & PRIMER-BASED qPCR REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 5: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 6: qPCR REAGENTS MARKET SIZE FOR CORE KITS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: qPCR REAGENTS MARKET SIZE FOR MASTERMIXES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: GLOBAL qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 9: qPCR REAGENTS MARKET SIZE FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: qPCR REAGENTS MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: qPCR REAGENTS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: qPCR REAGENTS MARKET SIZE FOR CROS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: qPCR REAGENTS MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: GLOBAL qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 15: qPCR REAGENTS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: qPCR REAGENTS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: qPCR REAGENTS MARKET SIZE FOR FORENSIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: qPCR REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: NORTH AMERICA: qPCR REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: U.S.: QPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 21: U.S.: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 22: U.S.: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 23: U.S.: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 24: CANADA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 25: CANADA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 26: CANADA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 27: CANADA: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 28: EUROPE: qPCR REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: GERMANY: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 30: GERMANY: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 31: GERMANY: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 32: GERMANY: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 33: U.K.: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 34: U.K.: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 35: U.K.: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 36: U.K.: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 37: FRANCE: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 38: FRANCE: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 39: FRANCE: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 40: FRANCE: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 41: ROE: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 42: ROE: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 43: ROE: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 44: ROE: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 45: ASIA-PACIFIC qPCR REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 46: JAPAN: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 47: JAPAN: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 48: JAPAN: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 49: JAPAN: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 50: CHINA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 51: CHINA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: CHINA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 53: CHINA: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 54: INDIA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 55: INDIA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: INDIA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 57: INDIA: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 58: ROAPAC: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 59: ROAPAC: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: ROAPAC: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 61: ROAPAC: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 62: ROW: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
  • TABLE 63: ROW: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: ROW: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 65: ROW: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 66: NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS, 2012-2015
  • TABLE 67: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2015
  • TABLE 68: MERGERS, DEMERGERS, AND ACQUISITIONS, 2012-2015
  • TABLE 69: GEOGRAPHICAL EXPANSIONS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: HEALTHCARE EXPENDITURE ACROSS KEY MARKETS, 2000 VS. 2012
  • FIGURE 3: HEALTHCARE SPENDING MATRIX: KEY MARKETS, 2013
  • FIGURE 4: GLOBAL RISE IN PROPORTION OF GERIATRIC POPULATION (2000-2013)
  • FIGURE 5: INCREASE IN AGING POPULATION, BY COUNTRY, 2005 VS. 2010
  • FIGURE 6: GLOBAL BURDEN OF CANCER, BY REGION, 2005-2030
  • FIGURE 7: RISING INCIDENCE OF CANCER ACROSS KEY REGIONS, 2008 VS. 2012
  • FIGURE 8: ANNUAL CRUDE BIRTH RATE ACROSS KEY GLOBAL MARKETS, 2011
  • FIGURE 9: PREVALENCE OF HIV INFECTIONS ACROSS THE GLOBE, BY REGION, 2013
  • FIGURE 10: GLOBAL OUTBREAK OF LEADING INFECTIOUS DISEASES, 1980-2010
  • FIGURE 11: RAPE AND HOMICIDE CASES ACROSS KEY REGIONS, 2003-2012
  • FIGURE 12: qPCR PRODUCTS VS. PCR MARKET: A COMPARATIVE STUDY
  • FIGURE 13: BOTTOM-UP APPROACH
  • FIGURE 14: TOP-DOWN APPROACH
  • FIGURE 15: DATA TRIANGULATION
  • FIGURE 16: ASSUMPTIONS FOR THE RESEARCH STUDY
  • FIGURE 17: NORTH AMERICA IS EXPECTED TO DOMINATE THE DYE-BASED AND PROBE & PRIMER-BASED qPCR REAGENTS MARKETS BY 2020
  • FIGURE 18: NORTH AMERICA IS EXPECTED TO DOMINATE THE qPCR CORE KITS & qPCR MASTERMIXES SEGMENTS BY 2020
  • FIGURE 19: HOSPITALS & DIAGNOSTIC CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE qPCR REAGENTS MARKET IN 2020
  • FIGURE 20: NORTH AMERICA IS EXPECTED TO DOMINATE THE qPCR REAGENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: TOP 3 MARKET PLAYERS TO HOLD ~3/4TH MARKET SHARE OF THE qPCR REAGENTS MARKET (2014)
  • FIGURE 22: ATTRACTIVE GROWTH OPPORTUNITIES IN THE qPCR REAGENTS MARKET
  • FIGURE 23: NORTH AMERICA IS EXPECTED TO DOMINATE THE DYE-BASED AND PROBE & PRIMER-BASED qPCR REAGENTS MARKETS TILL 2020
  • FIGURE 24: U.S. IS EXPECTED TO DOMINATE THE qPCR REAGENTS MARKET IN 2015
  • FIGURE 25: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF KEY qPCR REAGENT APPLICATION SEGMENTS IN 2015
  • FIGURE 26: CHINA AND INDIA TO LEAD THE MARKET DEMAND FOR qPCR REAGENTS AMONG KEY END USERS DURING THE FORECAST PERIOD
  • FIGURE 27: qPCR REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 28: HIV PREVALENCE, BY REGION, 2013
  • FIGURE 29: INCIDENCE OF NEW CANCER CASES WILL BE HIGH AMONG THE GERIATRIC POPULATION
  • FIGURE 30: TRADITIONAL PCR VS. qPCR: A COMPARATIVE STUDY
  • FIGURE 31: PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE-DEVELOPED VS. DEVELOPING COUNTRIES (2010-2012)
  • FIGURE 32: VALUE CHAIN ANALYSIS (2014): MAJOR VALUE IS ADDED DURING THE MANUFACTURING PHASE
  • FIGURE 33: qPCR REAGENTS MARKET: SUPPLY CHAIN (2014)
  • FIGURE 34: PRESENCE OF LARGE NUMBER OF NEW ENTRANTS INCREASES MARKET COMPETITION
  • FIGURE 35: DYE-BASED REAGENTS TO DOMINATE THE qPCR REAGENTS MARKET TILL 2020
  • FIGURE 36: qPCR CORE KITS TO DOMINATE THE qPCR REAGENTS MARKET REVENUE TILL 2020
  • FIGURE 37: HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE THE qPCR REAGENTS END-USER MARKET DURING FORECAST PERIOD (2015-2020)
  • FIGURE 38: NORTH AMERICA TO DOMINATE THE qPCR REAGENTS MARKET FOR FORENSIC LABORATORIES
  • FIGURE 39: DIAGNOSTIC APPLICATIONS TO DOMINATE THE qPCR REAGENTS APPLICATION MARKET TILL 2020
  • FIGURE 40: NORTH AMERICA: qPCR REAGENTS MARKET TRENDS (2015-2020)
  • FIGURE 41: EUROPE: qPCR REAGENTS MARKET TRENDS (2015-2020)
  • FIGURE 42: APAC: qPCR REAGENTS MARKET TRENDS (2015-2020)
  • FIGURE 43: PRODUCT DEVELOPMENT & COMMERCIALIZATION WAS ADOPTED BY MOST LEADING PLAYERS DURING 2012-2015
  • FIGURE 44: GLOBAL qPCR REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2014)
  • FIGURE 45: MAJORITY OF LEADING MARKET PLAYERS ARE FOCUSED ON PRODUCT LAUNCHES AND APPROVALS AS THEIR KEY GROWTH STRATEGY
  • FIGURE 46: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS* (2014)
  • FIGURE 47: LEADING HUMAN QPCR REAGENT MANUFACTURERS FOCUSED ON PRODUCT DEVELOPMENT & COMMERCIALIZATION TO STRENGTHEN THEIR MARKET POSITION
  • FIGURE 48: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 49: BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
  • FIGURE 50: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 51: QIAGEN N.V. : COMPANY SNAPSHOT
  • FIGURE 52: AGILENT TECHNOLOGIES, INC. : COMPANY SNAPSHOT
  • FIGURE 53: TAKARA BIO, INC.: COMPANY SNAPSHOT
  • FIGURE 54: AFFYMETRIX, INC.: COMPANY SNAPSHOT
  • FIGURE 55: SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.